US stocks had started last week on a positive note, with the Nasdaq notching a record close on Monday, as markets enthusiastically awaited quarterly results from major companies. Investors rejoiced positive news related to coronavirus vaccine candidates. AstraZeneca and the University of Oxford announced promising results from their covid-19 vaccine candidate in Phase 1 clinical
US stocks started the week on a strong note on Monday last week, as investors cheered news of positive trial results for covid-19 vaccine candidates. Pfizer reported that two of its vaccine candidates had been awarded FDA’s Fast Track designation. Moderna joined in to issue some encouraging data for its covid-19 candidate, showing that the
US stocks started the week on a positive note after China’s blue-chip stocks surged to multi-year highs. As coronavirus cases continued to rise in various states in the US and other parts of the world, tech stocks climbed, taking the Nasdaq to a new high. The US services index also returned to expansion territory, with
US markets started the week on a positive note despite a spike in new coronavirus cases. Various states in the US, including Texas and Florida, have reversed their reopening measures after witnessing a record rise in cases last week, including the highest single-day infections of 52,000 on Wednesday. Investors cheered news of Pfizer and German
